Cargando…
Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?
Parkinson’s disease (PD) is a neurodegenerative disorder whose aetiology remains unclear: degeneration involves several neurotransmission systems, resulting in a heterogeneous disease characterized by motor and non-motor symptoms. PD causes progressive disability that responds only to symptomatic th...
Autores principales: | Cova, Ilaria, Priori, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132920/ https://www.ncbi.nlm.nih.gov/pubmed/30145631 http://dx.doi.org/10.1007/s00702-018-1910-4 |
Ejemplares similares
-
Diagnostic accuracy of glabellar tap sign for Parkinson’s disease
por: Nuuttila, Simo, et al.
Publicado: (2021) -
Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice
por: Tönges, Lars, et al.
Publicado: (2022) -
Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022) -
The heterogeneity of Parkinson’s disease
por: Wüllner, Ullrich, et al.
Publicado: (2023) -
Diagnostic value of micrographia in Parkinson’s disease: a study with [(123)I]FP-CIT SPECT
por: Eklund, Mikael, et al.
Publicado: (2022)